HDL subtractions distribution in renal transplant recipients: Lack of evidence of a reduction of HDL2 particles

Nephron

Volumn 72, Issue 3, 1996, Pages 407-412

  Barbagallo, Carlo A ^a   Averna, Maurizio R ^c   Sparacino, Vito ^b   Cefalù, Angelo B ^a   Caputo, Flavia ^b   Noto, Davide ^a   Verghi, Francesca ^a   Notarbartolo, Alberto ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b Civic Hospital   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

HDL; Lipoproteins; Renal transplant recipients

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; AZATHIOPRINE; CHOLESTEROL; CYCLOSPORIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PREDNISONE; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; FEMALE; HEART PROTECTION; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RISK;

ADULT; AGED; APOLIPOPROTEINS; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; FEMALE; HUMANS; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LIPIDS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS;

EID: 0030029069     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188904     Document Type: Article

References (42)

1. Kasiske BL: Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 1984;84:985-992.
2. Bagdade D. C'asaretto A. Albers J: Effects of chronic uremia, hemodialysis and renal transplantation on plasma lipids and lipoproteins in man. J l.ab Clin Med 1976:87:37-48.
3. Ponticelli C. Barbi CL. Cantaluppi A. De Vecchi A, Arnioni G. Donati C. Cecchettin M: Lipid disorders in renal transplant recipients. Nephron 1978:20:189-195.
4. Divakar D, Bailey RR. Frampton CM. George PM, Wlamley TA. Murphy J: Hyperlipidemia in stable renal transplant recipients. Nephron 1991:59:423-428.
5. Barbagallo CM. Avcma MR. Sparacino V, Ga-lione A, Caputo F. Scafidi V, Amato S, Mancino C, Ccfalù AB. Notarbartolo A: Lp(a) levels in end-stage renal failure and renal transplantation. Nephron 1993:64:560-564.
6. Bagdade JD. Porte D Jr, Bicrman EL: Hypertriglyceridemia: A metabolic consequence of chronic renal failure. N Engl J Med 1968:279: 181-185.
7. Chan MK, Varghese Z, Moorhead JF: Lipid abnormalities in uremia, dialysis, and transplantation. Kidney lnt 1981:19:625-637.
8. Cassader M. Ruiu G. Gambino R, Alcmanno N. Triolo G, Pagano G: Lipoprotein-apoprotein changes in renal transplant recipients: A 2-year follow-up. Metabolism 1991:40:922-925.
9. Chan MK. Varghese Z, Persaud JW, Fernando ON. Moorhead JF: The role of multiple pharmacotherapy in the pathogenesis of hyperlipidemia after renal transplantation. Clin Nephrol 1981;15:309-313.
10. Vathsala A. Weinberg RB. Schoenbeg L. Grevel J. Goldstein RA. Van Buren CT, Lewris RM. Kahan BD: Lipid abnormalities in cyclos-porine-prednisonc-treated renal transplant recipients. Transplantation 1989:48:37-43.
11. Bittar AE, Ratclilïe PJ. Richardson AJ. Raine AEG. Jones L, Yudkin PL, Carter R. Mann JI. Morris PJ: The prevalence of hyperlipidemia in renal transplant recipients. Associations with immunosuppressive and antihypertensive therapy. Transplantation 1990:50:987-992.
12. Curtis JJ. Galla JH. Woodward SY. Rees ED. Luke EG: Effect of alternate day prednisone on plasma lipids in renal transplant patients. Kidney lnt 1982:22:42-47.
13. Savdie E, Gibston JC. Stewart JLI. Simons LA: High density lipoprotein in chronic renal failure and after renal transplantation. Br Med J 1979:1:928-930.
14. Joung K. Neumann R. Scholsz D. Nugcl E: Abnormalities in the composition of scrum high density lipoprotein in renal transplant recipients. Clin Nephrol 1982:17:191-194.
15. Ettingcr WH. Bender WL, Goldberg AP. Haz-zard WR: Lipoprotein lipid abnormalities in healthy renal transplant recipients: Persistence of low HDLi cholesterol. Nephron 1987:47: 17-21.
16. Atger V. Cambillau M, Guillcmain R. Farge D, Dreyfus G. Hamon S, Girard A, Carpentier A. Modti N: Serum lipid abnormalities in heart transplant recipients: Predominance of HDLi-like particles in the HDL pattern. Atherosclerosis 1990:81:103-110.
17. Zimmerman J. Fainaru M. Eisenberg S: The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: A prospective study. Metabolism 1984;33:521-526.
18. Averna MR. Barbagallo CM. Sparacino V. C'a-puto F. Mancino C. Calabrese S. Notarbartolo A: Follow-up of lipid and apoprotein levels in renal transplant recipients. Nephron 1991:58: 255-256.
19. Blanche PJ, Gong EL. Forte TM. Nichols AV: Characterization of human high-density lipoproteins by gradient gel electrophoresis. Bio-chim BiophysActa 1981:665:408-419.
20. Johansson J. Carlson LA. Landou C. Hamsten A: High density lipoproteins and coronary atherosclerosis. A strong inverse relation with the largest particles is confined to normotriglyceri-demic patients. Arteriosclcr Thromb 1991:11: 174-182.
21. Barbagallo CM. Averna M R, Novo S. Nolo D, Cavera G. Liquori M. Marino G. Notarbartolo A: Distribution of high density lipoprotein subtractions in asymptomatic extracranial carotid atherosclerosis. Eur J Intern Med 1994:5:305-309.
22. Roschlau P: Enzymatischc Bestimmung des Gesamt-Cholestcrins in Serum. Client Klin Biochem 1974;12:226-227.
23. Wahalefeld AW: Triglyceride determination after enzymatic hydrolysis: in Bergmeyer HU (ed): Methods of Enzymatic Analysis. New York. Academic Press. 1974, vol 4. pp 1831-1835.
24. Lopez-Virella HF. Stone P. Ellis J. Coltwell LA: Cholesterol determination in the HDL separated by precipitation with polvanions. J Lipid Res 1970:11:583-595.
25. Friedewald WT. Levy RJ, Frederickson DS: Estimation of the concentration of low density lipoproteins cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1980:18:499-502.
26. Becker W, Schafter W. Ziebenbcin W: Standardization of immunochemical quantitation of human apolipoprotein A and B. Ricerca Clin Lab 1980:10:203-212.
27. Averna MR. Barbagallo CM. Galionc A. Carroccio A. Labisi M. Marino G. Montalto CI. Notarbartolo A: Serum apolipoprotein profile of hypcrtriglyceridemic patients with chronic renal failure on hemodialytic therapy: A comparison with type IV hyperlipoproteinemia. Metabolism 1989;38:601-602.
28. Havel RJ, Edcr HA, Bragdon JH: The distribution and chemical composition of ultracentri-fugallv separated lipoproteins in human serum. J Clin Invest 1955:34:1345-1353.
29. Verdery RB. Bcnham DF. Baldwin HL. Goldberg PA. Nichols AV: Measurement of normative HDL subfraction cholesterol levels by Gaussian summation analysis of gradient gels. J Lipid Res 1989:30:1085-1095.
30. Snedecor GW. Cochran WG: Statistical Methods. Ames. Iowa State University Press. 1964.
31. Ballantyne FC. Clarke FS. Simpson HS, Bal-lantyne D: High density and low density lipoprotein subfractions in survivors of myocardial infarction and control subjects. Metabolism 1982;31:433-437.
32. Arnadottir M. Thyscll H, Nilsson-Ehle P: Lipoprotein levels and post-heparin lipase activities in kidney transplant recipients: Ciclosporin-versus nonciclosporin-treated patients. Am J Nephrol 1991;11:391-396.
33. Nemunaitis L. Deeg HJ. Yee GC: High cyclosporin levels after bone marrow' transplantation associated with hypertriglyceridemia. Lancet 1986:Vol ii:744-745.
34. Ballantyne CM, Podct EJ, Patsch WP. Harati Y. Appel V. Gotto AM Jr. Young JB: Effects of cyclosporine therapy on plasma lipoprotein levels. JAMA 1989:262:53-56.
35. Bagdade JD, Albers JJ: Plasma high density lipoprotein concentration in chronic hemodialysis and renal transplant patients. N Engl J Med 1977;296:1436-1439.
36. Becker DM. Chamberlain B. Swank R. Hegc-wald MG. Girardct R. Baughman KL, Kwite-rovich PO. Pearson TA, Ettinger WH. Renc-lund D: Relationships between corticosteroid exposure and plasma lipid levels in heart transplant recipients. Am J Med 1988:85:632-638.
37. Drukker A. Turner C. Start K. Munian A. Wass V. Haycock G. Chantier C: Hyperlipidemia after renal transplantation in children on alternate day corticosteroid therapy. Clin Nephrol 1986:26:140-145.
38. Eisenberg S: High density lipoprotein metabolism.! Lipid Res 1984:25:1017-1058.
39. Alger V, Leclerc T, Cambillau M. Guillemain R, Marti C, Moatti N. Girard A: Elevated high density lipoprotein concentrations in heart transplant recipients arc related to impaired plasma cholestervl ester transfer and hepatic lipase activity. Atherosclerosis 1993; 103:29-41
40. Moulin P. Appel GB. Ginsberg HN. Tall A: Increased concentration of plasma cholcsteryl ester transfer protein in nephrotic syndrome: Role in dyslipidemia. J Lipid Res 1992:32: 1817-1822.
41. Johansson J, Egberg N. Johnsson H. Carlson L.A: Serum lipoproteins and hemostatic function in intermittent claudication. Arteriosclcr Thromb 1993:13:1441-1448.
42. Williams PT, Vranizan KM. Austin M. Krauss RM: Associations of age, adiposity, alcohol intake, menstrual status, and estrogen therapy with high density lipoprotein subclasses. Artc-rioscler Thromb 1993:13:1654-1661.